18F-FES PET/CT's Additional Clinical Value in ER+ BC

Fudan University

Status: Completed

Conditions: Breast Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT04006626

YOUNGBC-7

Details and patient eligibility

About

To figure out whethetr 18F-FES PET/CT could influence the staging and management of newly diagnosed Oestrogen Receptor-positive Breast Cancer Patients.

Enrollment: 19 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with newly diagnosed immunohistochemical confirmed oestrogen receptor (ER)-positive breast cancer
• Patients underwent both 18F-FES PET/CT and 18F-FDG PET/CT in Fudan University Shanghai Cancer Center within 1 week after diagnosis
• Patients with available medical history

Exclusion criteria

• Patients with incomplete medical history

Trial design

19 participants in 2 patient groups

PET group

Description:

the staging and management of newly diagnosed ER+ Breast Cancer Patients based on 18F-FDG PET/CT

FES group

Description:

the staging and management of newly diagnosed ER+ Breast Cancer Patients based on 18F-FDG PET/CT and 18F-FES PET/CT